CeriBell, Inc. - Common Stock (NQ:CBLL)
Price and Volume
Detailed Quote| Volume | 29 |
| Open | 16.75 |
| Bid (Size) | 16.75 (100) |
| Ask (Size) | 16.96 (200) |
| Prev. Close | 16.75 |
| Today's Range | 16.75 - 16.75 |
| 52wk Range | 10.85 - 24.33 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
CeriBell (CBLL) Q4 2025 Earnings Call Transcript ↗
February 24, 2026
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
Ceribell to Participate in Upcoming March Investor Conferences
February 18, 2026
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Global AI Infrastructure Shift Ignites Biotech Growth Phase
December 09, 2025
CeriBell (CBLL) Q3 2025 Earnings Call Transcript ↗
November 09, 2025
Ceribell Reports Third Quarter 2025 Financial Results
November 04, 2025
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
September 22, 2025
CeriBell (CBLL) Q2 Revenue Jumps 38% ↗
August 06, 2025
Frequently Asked Questions
Is CeriBell, Inc. - Common Stock publicly traded?
Yes, CeriBell, Inc. - Common Stock is publicly traded.
What exchange does CeriBell, Inc. - Common Stock trade on?
CeriBell, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CeriBell, Inc. - Common Stock?
The ticker symbol for CeriBell, Inc. - Common Stock is CBLL on the Nasdaq Stock Market
What is the current price of CeriBell, Inc. - Common Stock?
The current price of CeriBell, Inc. - Common Stock is 16.75
When was CeriBell, Inc. - Common Stock last traded?
The last trade of CeriBell, Inc. - Common Stock was at 05/12/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube